Stock DRREDDY DR. REDDY'S LABORATORIES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Dr. Reddy's Laboratories Limited

Equities

DRREDDY

INE089A01023

Pharmaceuticals

Market Closed - Bombay S.E.
Other stock markets
 11:00:50 26/04/2024 BST 		5-day change 1st Jan Change
6,253 INR +0.58% Intraday chart for Dr. Reddy's Laboratories Limited +5.23% +7.85%
04-26 Asian Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading, End Week Up 3.5% MT
04-25 Tech Stocks Lead Asian Equities Traded in the US as American Depositary Receipts Lower in Thursday Trading MT

Business Summary

Dr. Reddy's Laboratories specializes in developing, producing, and selling pharmaceutical products. Net sales break down by activity as follows:

- sales of generic medications (79.9%): brand-name or generic prescription medications and OTC medicines;

- sales of active ingredients (15.7%). The group also supplies customized pharmaceutical services;

- other (4.4%): sales of generic biopharmaceutical products, development of molecular agents, etc.

Net sales are distributed geographically as follows: India (18.8%), the United States (45%), Russia (9.9%) and other (26.3%).

Number of employees: 25,863

Sales per Business

INR in Million2022Weight2023Weight Delta
Global Generics
86.9 %
179,170 83.6 % 213,768 86.9 % +19.31%
Pharmaceutical Services and Active Ingredients
11.8 %
30,740 14.3 % 29,069 11.8 % -5.44%
Others
1.2 %
2,870 1.3 % 3,042 1.2 % +5.99%

Sales per region

INR in Million2022Weight2023Weight Delta
United States
43.4 %
80,564 37.6 % 106,683 43.4 % +32.42%
Others
27.4 %
68,962 32.2 % 67,469 27.4 % -2.16%
India
20.5 %
43,986 20.5 % 50,499 20.5 % +14.81%
Russia
8.6 %
20,879 9.7 % 21,228 8.6 % +1.67%

Managers

Managers TitleAgeSince
Erez Israeli CEO
 Chief Executive Officer 57 01/04/18
Parag Agarwal DFI
 Director of Finance/CFO - 01/11/20
Satish Kallam Reddy CHM
 Chairman 56 17/01/93
Gunupati Prasad CHM
 Chairman 63 07/04/86
B. Phanimitra CTO
 Chief Tech/Sci/R&D Officer - 31/07/23
K. Randhir Singh CMP
 Compliance Officer - 16/03/22
Archana Bhaskar IRO
 Public Communications Contact 57 31/05/17
Amith Agarwal IRC
 Investor Relations Contact - -
Jayanth Sridhar PRN
 Corporate Officer/Principal - -
Vivek Mittal LAW
 General Counsel - 30/04/21

Members of the board

Members of the board TitleAgeSince
Gunupati Prasad CHM
 Chairman 63 07/04/86
Satish Kallam Reddy CHM
 Chairman 56 17/01/93
Kalpana Morparia BRD
 Director/Board Member 73 04/06/07
Shikha Sharma BRD
 Director/Board Member 64 30/01/19
Leo Puri BRD
 Director/Board Member 63 24/10/18
Claudio Albrecht BRD
 Director/Board Member - 09/05/23
Arun M. Kumar BRD
 Director/Board Member 72 31/07/22
Sanjiv Mehta BRD
 Director/Board Member 63 12-28
Kodumudi P. Krishnan BRD
 Director/Board Member 64 06/01/22
Alpna Seth BRD
 Director/Board Member 60 18/09/23

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 166,874,039 152,715,641 ( 91.52 %) 345,564 ( 0.2071 %) 91.52 %

Shareholders

NameEquities%Valuation
APS Trust
20.59 %
34,345,308 20.59 % 2 535 M ₹
Life Insurance Corporation of India (Investment Portfolio)
5.593 %
9,328,967 5.593 % 688 M ₹
Reddy Satish Kallam Family
3.311 %
5,523,677 3.311 % 408 M ₹
First Sentier Investors (Australia) IM Ltd.
2.193 %
3,658,520 2.193 % 270 M ₹
HDFC Asset Management Co. Ltd. (Invt Mgmt)
1.621 %
2,703,229 1.621 % 199 M ₹
SBI Funds Management Ltd.
1.603 %
2,673,659 1.603 % 197 M ₹
Prasad Gunupati Venkateswara Family
1.525 %
2,543,418 1.525 % 188 M ₹
GIC Pte Ltd. (Investment Management)
1.241 %
2,070,475 1.241 % 153 M ₹
UTI Asset Management Co. Ltd. (Investment Management)
1.056 %
1,760,938 1.056 % 130 M ₹
Nippon Life India Asset Management Ltd. (Invt Mgmt)
0.6835 %
1,140,150 0.6835 % 84 M ₹
NameEquities%Valuation
RBC Trust Co. Delaware Ltd.
1.352 %
2,254,449 1.352 % 165 M ₹
BlackRock Advisors LLC
1.308 %
2,182,135 1.308 % 160 M ₹
Robeco Alternative Investments
1.184 %
1,974,720 1.184 % 145 M ₹
Renaissance Technologies LLC
1.116 %
1,860,795 1.116 % 136 M ₹
Goldman Sachs Asset Management LP
1.101 %
1,837,163 1.101 % 135 M ₹
Aikya Investment Management Ltd.
0.6574 %
1,096,573 0.6574 % 80 M ₹
Vanguard Fiduciary Trust Co.
0.6224 %
1,038,258 0.6224 % 76 M ₹
Dimensional Fund Advisors LP
0.4972 %
829,310 0.4972 % 61 M ₹
Morgan Stanley Capital Services LLC
0.4907 %
818,552 0.4907 % 60 M ₹
Numeric Investors LLC
0.4587 %
765,193 0.4587 % 56 M ₹

Company contact information

Dr. Reddy's Laboratories Ltd.

Door No. 8-2-337 Road No. 3

500034, Hyderabad

+91 40 4900 2900

http://www.drreddys.com
address Dr. Reddy's Laboratories Limited(DRREDDY)

Group companies

NameCategory and Sector
Aurigene Discovery Technologies Ltd.
Logo Aurigene Discovery Technologies Ltd.

Aurigene Discovery Technologies Ltd.

BiotechnologyHealth Technology

Aurigene Discovery Technologies Ltd. operates as biotechnology company. It offers research services such as integrated research and stand-alone research. The company is headquartered in Bangalore, India.

Biotechnology
Dr. Reddy's Laboratories SA
Logo Dr. Reddy's Laboratories SA

Dr. Reddy's Laboratories SA

Pharmaceuticals: MajorHealth Technology

Part of Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories SA is a Swiss company that develops, manufactures and sells pharmaceutical products. The private company is based in Basel, Switzerland.

Pharmaceuticals: Major
Aurigene Pharmaceutical Services Ltd.
Logo Aurigene Pharmaceutical Services Ltd.

Aurigene Pharmaceutical Services Ltd.

BiotechnologyHealth Technology

Aurigene Pharmaceutical Services Ltd. is a contract research, development, and manufacturing organization. It offer integrated and standalone services for medicinal chemistry, biology, preclinical services, DMPK studies, development, and manufacturing for clinical phase I-III programs. The company is headquartered in Bangalore, India.

Biotechnology

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for Dr. Reddy's Laboratories Limited

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
35
Last Close Price
6,253 INR
Average target price
6,005 INR
Spread / Average Target
-3.97%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
DR. REDDY'S LABORATORIES LIMITED Stock Dr. Reddy's Laboratories Limited
+7.85% 12.49B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.83% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+27.00% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.76% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.00% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.09% 231B
NOVARTIS AG Stock Novartis AG
+5.46% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.61% 195B
AMGEN INC. Stock Amgen Inc.
-6.26% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. DRREDDY Stock
  4. Company Dr. Reddy's Laboratories Limited